The market expects Quest Diagnostics (DGX) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus ...

Quest Diagnostics DGX is set to release its first-quarter 2025 results on April 22, before the market opens. The renowned ...

SandboxAQ today announced a collaboration with NVIDIA to accelerate breakthrough innovations across biopharma, chemicals, advanced materials, financial services, cybersecurity, navigation, and medical ...

Nvidia Corp. today announced plans to mass-produce artificial intelligence supercomputers in the U.S.

BofA analyst Michael Ryskin raised the firm’s price target on Quest Diagnostics (DGX) to $198 from $190 and keeps a Buy rating on the shares.

So, NVIDIA and Google Cloud are teaming up to help companies tap into Google’s powerful Gemini AI models and specifically ...

When it comes to artificial intelligence, context is everything. The same thing holds true for human intelligence, so it ...

Before Silicon Valley was all apps and ad tech, it was about atoms—not just bits. The future of innovation depends on ...

NVIDIA brings agentic AI reasoning to enterprises with Google Cloud; AT&T deploys fiber for Jericho's data center; Google ...

Being an Elite Partner in the NVIDIA Partner Network (NPN) and DGX-Ready Managed Service Partner demonstrates ePlus' ability to successfully provide expertise, through its extensive team of resources, ...

Barclays analyst Luke Sergott maintained a Hold rating on Quest Diagnostics (DGX – Research Report) today and set a price target of $175.00.

Quest Diagnostics Inc. closed 8.28% below its 52-week high of $178.87, which the company reached on March 10th.